Lipids

, 33:461 | Cite as

Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status

  • Kalanithi Nesaretnam
  • Ruth Stephen
  • Ray Dils
  • Philippa Darbre
Article

Abstract

Potential antiproliferative effects of tocotrienols, the major vitamin E component in palm oil, were investigated on the growth of both estrogen-responsive (ER+) MCF7 human breast cancer cells and estrogen-unresponsive (ER-) MDA-MD-231 human breast cancer cells, and effects were compared with those of α-tocopherol (αT). The tocotrienol-rich fraction (TRF) of palm oil inhibited growth of MCF7 cells in both the presence and absence of estradiol with a nonlinear dose-response but such that complete suppression of growth was achieved at 8 μg/mL. MDA-MB-231 cells were also inhibited by TRF but with a linear dose-response such that 20 μg/mL TRF was needed for complete growth suppression. Separation of the TRF into individual tocotrienols revealed that all fractions could inhibit growth of both ER+ and ER- cells and of ER+ cells in both the presence and absence of estradiol. However, the γ- and δ-fractions were the most inhibitory. Complete inhibition of MCF7 cell growth was achieved at 6 μg/mL of γ-tocotrienol/δ-tocotrienol (γT3/δT3) in the absence of estradiol and 10μm/mL of δT3 in the presence of estradiol, whereas complete suppression of MDA-MB-231 cell growth was not achieved even at concentrations of 10μg/mL of δT3. By contrast to these inhibitory effects of tocotrienols, αT had no inhibitory effect on MCF7 cell growth in either the presence or the absence of estradiol, nor on MDA-MB-231 cell growth. These results confirm studies using other sublines of human breast cancer cells and demonstrate that tocotrienols can exert direct inhibitory effects on the growth of breast cancer cells. In searching for the mechanism of inhibition, studies of the effects of TRF on estrogen-regulated pS2 gene expression in MCF7 cells showed that tocotrienols do not act via an estrogen receptor-mediated pathway and must therefore act differently from estrogen antagonists. Furthermore, tocotrienols did not increase levels of growth-inhibitory insulin-like growth factor binding proteins (IGFBP) in MCF7 cells, implying also a different mechanism from that proposed for retinoic acid inhibition of estrogen-responsive breast cancer cell growth. Inhibition of the growth of breast cancer cells by tocotrienols could have important clinical implications not only because tocotrienols are able to inhibit the growth of both ER+ and ER- phenotypes but also because ER+ cells could be growth-inhibited in the presence as well as in the absence of estradiol. Future clinical applications of TRF could come from potential growth suppression of ER+ breast cancer cells otherwise resistant to growth inhibition by antiestrogens and retinoic acid.

Abbreviations

DCFCS

dextran-charcoal treated fetal calf serum

ER+

estrogen receptor positive (containing estrogen receptors)

ER−

estrogen receptor negative (lacking estrogen receptors)

FCS

fetal calf serum

IGF

insulin-like growth factor

IGFBP

insulin-like growth factor binding protein

PBS

phosphate-buffered saline

SDS

sodium dodecyl sulfate

αT

α-tocopherol

αT3

α-tocotrienol

γT3

γ-tocotrienol

δT3

δ-tocotrienol

TRF

tocotrienol-rich fraction

References

  1. 1.
    Sebrell, W.H., and Harris, R.S. (1972) The Vitamins, 2nd edn., Vol. 5, pp. 172–173, Academic Press, New York.Google Scholar
  2. 2.
    Tappel, A.L. (1972) Vitamin E and Free Radical Peroxidation of Lipids, Ann. N.Y. Acad. Sci. 203, 12.PubMedGoogle Scholar
  3. 3.
    Burton, G.W., and Ingold, K.U. (1989) Vitamin E as in vitro and in vivo Antioxidant, Ann. N.Y. Acad. Sci. 570, 7–22.PubMedGoogle Scholar
  4. 4.
    Goh, S.H., Hew, N.F., Ong, A.S.H., Choo, Y.M., and Brumby, S. (1990) Tocotrienols from Palm Oil: Electron Spin Resonance Spectra of Tocotrienoxyl Radicals, J. Am. Oil Chem. Soc. 67, 250–254.Google Scholar
  5. 5.
    Serbinova, E., Kagan, V., Han, D., and Packer, L. (1991) Free Radical Recycling and Intermembrane Mobility in the Antioxidation Properties of Alpha-Tocopherol and Alpha-Tocotrienol, Free Radicals Biol. Med. 10, 263–275.CrossRefGoogle Scholar
  6. 6.
    Ong, A.S.H. (1993) Natural Sources of Tocotrienols in Vitamin E in Health and Disease (Packer, L., and Fuchs, J., eds.) Marcel Dekker, New York, pp. 3–8.Google Scholar
  7. 7.
    Gould, M.N., Haag, J.D., Kennan, W.S., Tanner, M.A., and Elson, C.E. (1991) A Comparison of Tocopherol and Tocotrienol for the Chemoprevention of Chemically Induced Rat Mammary Tumors, Am. J. Clin Nutr. 53, 1068s-1070s.PubMedGoogle Scholar
  8. 8.
    Tan, B. (1992) Antitumor Effects of Palm Carotenes and Tocotrienols in HRS/J Hairless Female Mice, Nutr. Res. 12, S163–173.CrossRefGoogle Scholar
  9. 9.
    Sylvester, P.W., Russell, M., Ip, M.M., and Ip, C. (1986) Comparative Effects of Different Animal and Vegetable Fats Before and During Carcinogen Administration on Mammary Tumourigenesis, Sexual Maturation and Endocrine Function in Rats, Cancer Res. 46, 757–762.PubMedGoogle Scholar
  10. 10.
    Sundram, K., Khor, H.T., Ong, A.S.H., and Pathmanathan, R. (1989) Effect of Dietary Palm Oils on Mammary Carcinogenesis in Female Rats Induced by 7, 12 Dimethylbenz(α)anthracene, Cancer Res. 49, 1447–1451.PubMedGoogle Scholar
  11. 11.
    Kritchevsky, D., Weber, M.M., and Klurfeld, D.M. (1992) Influence of Different Fats (Soyabean Oil, Palm Olein or Hydrogenated Oil) on Chemically-Induced Mammary Tumors in Rats, Nutr. Res. 12, S175–179.CrossRefGoogle Scholar
  12. 12.
    Nesaretnam, K., Khor, H.T., Ganeson, J., Chong, Y.H., Sundram, K., and Gapor, A. (1992) The Effect of Vitamin E Tocotrienols from Palm Oil on Chemically Induced Mammary Carcinogenesis in Female Rats, Nutr. Res. 12, 879–892.CrossRefGoogle Scholar
  13. 13.
    Nesaretnam, K., Guthrie, N., Chambers, A.F., and Carroll, K.K. (1995) Effect of Tocotrienols on the Growth of a Human Breast Cancer Cell Line in Culture, Lipids 30, 1139–1143.PubMedGoogle Scholar
  14. 14.
    Beck, J.S. (ed.) (1989) Oestrogen and the Human Breast, Proc. Roy. Soc. Edin. 95B, 1–307.Google Scholar
  15. 15.
    Stewart, H.J., Anderson, T.J., and Forrest, A.P.M. (eds.) (1991) Breast Cancer: New Approaches, Brit Med. Bull. 47, 251–518.Google Scholar
  16. 16.
    Darbre, P.D., and Daly, R.J. (1989) Effects of Oestrogen on Human Breast Cancer Cells in Culture, Proc. Roy. Soc. Edin. 95B, 119–132.Google Scholar
  17. 17.
    Lippman, M.E., and Dickson, R.B. (1990) Regulatory Mechanisms in Breast Cancer: Advances in Cellular and Molecular Biology of Breast Cancer, Kluwer Academic Publishers, Boston, pp. 1–452.Google Scholar
  18. 18.
    Engel, L.W., Young, N.A., Tralka, T.S., Lippman, M.E., O'Brien, S.J., and Joyce, M.J. (1978) Establishment and Characterisation of Three New Continuous Cell Lines Derived from Human Breast Carcinomas, Cancer Res. 38, 3352–3364.PubMedGoogle Scholar
  19. 19.
    Osborne, C.K., Hobbs, K., and Trent, J.M. (1987) Biological Differences Among MCF-7 Human Breast Cancer Cell Lines from Different Laboratories, Breast Cancer Res. Treat. 9, 111–121.PubMedCrossRefGoogle Scholar
  20. 20.
    Yee, D. (1992) Insulin-Like Growth Factors in Breast Cancer, Breast Cancer Res. Treat. 22, 1–106.CrossRefGoogle Scholar
  21. 21.
    Kelley, K.M., Oh, Y., Gargosky, S.E., Gucev, Z., Matsumoto, T., Hwa, V., Ng, L., Simpson, D.M., and Rosenfeld, R.G. (1996) Insulin-Like Growth Factor Binding Proteins (IGFBPs) and Their Regulatory Dynamics, Int. J. Biochem. Cell Biol. 28, 619–637.PubMedCrossRefGoogle Scholar
  22. 22.
    Yee, D., Cullen, K.J., Paik, S., Perdue, J.F., Hampton, B., Schwartz, A., Lippman, M.E., and Rosen, N. (1988) Insulin-Like Growth Factor II mRNA Expression in Human Breast Cancer, Cancer Res. 48, 6691–6696.PubMedGoogle Scholar
  23. 23.
    Stewart, A.J., Johnson, M.D., May, F.E.B., and Westley, B.R. (1990) Role of Insulin-Like Growth Factors and the Type I Insulin-Like Growth Factor Receptor in the Estrogen-Stimulated Proliferation of Human Breast Cancer Cells, J. Biol. Chem. 265, 21172–21178.PubMedGoogle Scholar
  24. 24.
    Pratt, S.E., and Pollock, M.N. (1993) Estrogen and Antioestrogen Modulation of MCF-7 Human Breast Cancer Cell Proliferation Is Associated with Specific Alterations in Accumulation of Insulin-Like Growth Factor Binding Proteins in Conditioned Media, Cancer Res. 53, 5193–5198.PubMedGoogle Scholar
  25. 25.
    Parker, M.G. (ed.) (1991) Nuclear Hormone Receptors: Molecular Mechanisms, Cellular Functions, Clinical Abnormalities, Academic Press, London, pp. 1–404.Google Scholar
  26. 26.
    Parker, M.G. (ed.) (1993) Steroid Hormone Action, IRL Press, Oxford, pp. 1–210.Google Scholar
  27. 27.
    Wakeling, A.E. (1993) The Future of New Pure Antiestrogens in Clinical Breast Cancer, Breast Cancer Res. Treat. 25, 1–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Perachiotti, A., and Darbre, P.D. (1994) Coculture Inserts Possess an Intrinsic Ability to Alter Growth Regulation of Human Breast Cancer Cells, Exp. Cell Res. 213, 404–411.PubMedCrossRefGoogle Scholar
  29. 29.
    Masiakowski, P., Breathnach, R., Bloch, J., Gannon, F., Krust, A., and Chambon, P. (1982) Cloning of cDNA Sequences of Hormone-Regulated Genes from the MCF-7 Human Breast Cancer Cell Line, Nucleic Acids Res. 10, 7895–7903.PubMedGoogle Scholar
  30. 30.
    Sundram, K., and Gapor, A. (1992) Vitamin E from Palm Oil Its Extraction and Nutritional Properties, Lipid Technolog. Peter J. Barnes, Bridgwater, England, November/December, pp. 137–141.Google Scholar
  31. 31.
    Darbre, P., Yates, J., Curtis, S., and King, R.J.B. (1983) Effect of Estradiol on Human Breast Cancer Cells in Culture, Cancer Res. 43, 349–354.PubMedGoogle Scholar
  32. 32.
    Maniatis, T., Fitsch, F.F., and Sambrook, J. (1982) Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Laboratory, New York, pp. 1–545.Google Scholar
  33. 33.
    Brown, A.M.C., Jeltsch, J.M., Roberts, M., and Chambon, P. (1984) Activation of pS2 Gene Transcription Is a Primary Response to Estrogen in the Human Breast Cancer Cell Line MCF-7, Proc. Natl. Acad. Sci. USA 81, 6344–6348.PubMedCrossRefGoogle Scholar
  34. 34.
    Hossenlopp, P., Seurin, D., Segovia-Quinson, B., Hardouin, S., and Binoux, M. (1986) Analysis of Serum Insulin-Like Growth Factor Binding Proteins Using Western Blotting: Use of the Method for Titration of the Binding Proteins and Competitive Binding Studies, Anal. Biochem. 154, 138–143.PubMedCrossRefGoogle Scholar
  35. 35.
    Salacinski, P.R.P., McLean, C., Sykes, J.E.C., Clement-Jones, V.V., and Lowry, P.J. (1981) Iodination of Proteins, Glycoproteins and Peptides Using a Solid Phase Oxidising Agent 1,3,4,6-Tetrachloro-3,6-diphenylglycouril (Iodogen), Anal. Biochem. 117, 136–146.PubMedCrossRefGoogle Scholar
  36. 36.
    Corcoran, D., Perachiotti, A., and Darbre, P.D. (1996) Increased Autocrine Production of Insulin-Like Growth Factor II (IGF-II) Alters Serum Sensitivity of MCF7 Human Breast Cancer Cell Proliferation, Cell Prolif. 29, 479–493.PubMedGoogle Scholar
  37. 37.
    Carroll, K.K., Guthrie, N., Nesaretnam, K., Gapor, A., and Chambers, A.F. (1995) Anti-Cancer Properties of Tocotrienols from Palm Oil, in Nutrition, Lipids, Health and Disease (Ong, A.S.H., Niki, E., and Packer, L., eds.) AOCS Press, Champaign, pp. 117–121.Google Scholar
  38. 38.
    Guthrie, N., Chambers, A.F., Gapor, A., and Carroll, K.K. (1995) In vitro Inhibition of Proliferation of Receptor-Positive MCF-7 Human Breast Cancer Cells by Palm Oil Tocotrienols, FASEB J. 9, A968 (abstract 5735).Google Scholar
  39. 39.
    Guthrie, N., Gapor, A., Chambers, A.F., and Carroll, K.K. (1997) Inhibition of Proliferation of Estrogen Receptor-Negative MDA-MB-435 and-Positive MCF-7 Human Breast Cancer Cells by Palm Oil Tocotrienols and Tamoxifen, Alone and in Combination, J. Nutr 127, 544S-548S.PubMedGoogle Scholar
  40. 40.
    Guthrie, N., Gapor, A., Chambers, A.F., and Carroll, K.K. (1997) Palm Oil Tocotrienols and Plant Flavonoids Act Synergistically to Inhibit Proliferation of Estrogen Receptor-Negative MDA-MB-231 and-Positive MCF-7 Human Breast Cancer Cells in Culture, Asia Pacific J. Clin. Nutr. 6, 41–45.Google Scholar
  41. 41.
    Kyprianou, N., English, H.F., Davidson, N.E., and Isaacs, J.T. (1991) Programmed Cell Death During Regression of the MCF-7 Human Breast Cancer Following Estrogen Ablation, Cancer Res. 51, 162–166.PubMedGoogle Scholar
  42. 42.
    Tenniswood, M.P., Guenette, R.S., Lakins, J., Mooibroek, M., Wong, P., and Welsch, J.E. (1992) Active Cell Death in Hormone-Dependent Tissues, Cancer Metastasis Rev. 11, 197–220.PubMedCrossRefGoogle Scholar
  43. 43.
    Warri, A.M., Huovinen, R.L., Martikainen, P.M., and Harkonen, P.L. (1993) Apoptosis in Toremifene-Induced Growth Inhibition of Human Breast Cancer Cells in vivo and in vitro, J. Natl. Cancer. Inst. 85, 1412–1418.PubMedGoogle Scholar
  44. 44.
    Pagliacci, M.C., Tognellini, R., Grignani, F., and Nicoletti, I. (1991) Inhibition of Human Breast Cancer Cell (MCF-7) Growth in vitro by Somatostatin Analog SMS 201-995: Effects on Cell Cycle Parameters and Apoptotic Cell Death, Endocrinology 129, 2555–2562.PubMedCrossRefGoogle Scholar
  45. 45.
    Armstrong, D.K., Isaacs, J.T., Ottaviano, Y.L., and Davidson, N.E. (1992) Programmed Cell Death in an Estrogen-Independent Human Breast Cancer Cell Line MDA-MB-468, Cancer Res. 52, 3418–3424.PubMedGoogle Scholar
  46. 46.
    McCloskey, D.E., Casero, R.A., Woster, P.M., and Davidson, N.E. (1995) Induction of Programmed Cell Death in Human Breast Cancer Cells by an Unsymmetrically Alkylated Polyamine Analogue, Cancer Res. 55, 3233–3236.PubMedGoogle Scholar
  47. 47.
    Chatelain, E., Boscoboinik, D.O., Bartoli, G.M., Kagan, V.E., Gey, F.K., Packer, L., and Azzi, A. (1993) Inhibition of Smooth Muscle Cell Proliferation and Protein Kinase C Activity by Tocopherols and Tocotrienols, Biochim. Biophys. Acta 1176, 83–89.PubMedCrossRefGoogle Scholar
  48. 48.
    Gundimeda, U., Chen, Z.H., and Gopalakrishna, R. (1996) Tamoxifen Modulates Protein Kinase C via Oxidative Stress in Estrogen Receptor-Negative Breast Cancer Cells, J. Biol. Chem. 271, 13504–13514.PubMedCrossRefGoogle Scholar
  49. 49.
    Koba, K., Abe, K., Ikeda, I., and Sugano, M. (1992) Effects of Alpha-Tocopherol and Tocotrienols on Blood Pressure and Linoleic Acid Metabolism in the Spontaneously Hypertensive Rat, Biosci. Biotechnol. Biochem. 56, 1420–1423.PubMedCrossRefGoogle Scholar
  50. 50.
    Rose, D.P., Connolly, J.M., and Liu, X.H. (1994) Effects of Linoleic Acid on the Growth and Metastasis of Two Human Breast Cancer Cell Lines in Nude Mice and the Invasive Capacity of These Cell Lines in vitro, Cancer Res. 54, 6557–6562.PubMedGoogle Scholar
  51. 51.
    Glover, J.F., Irwin, J.T., and Darbre, P.D. (1988) Interaction of Phenol Red with Estrogenic and Antiestrogenic Action on Growth of Human Breast Cancer Cells ZR-75-1 and T-47-D, Cancer Res. 48, 3693–3697.PubMedGoogle Scholar
  52. 52.
    Gucev, Z.S., Oh, Y., Kelley, K.M., and Rosenfeld, R.G. (1996) Insulin-Like Growth Factor Binding Protein 3 Mediates Retinoic Acid- and Transforming Growth Factor β2-Induced Growth Inhibition in Human Breast Cancer Cells, Cancer Res. 56, 1545–1550.PubMedGoogle Scholar
  53. 53.
    Darbre, P.D., and Daly, R.J. (1990) Transition of Human Breast Cancer Cells from an Oestrogen Responsive to Unresponsive State, J. Steroid Biochem. Molec. Biol. 37, 753–763.PubMedCrossRefGoogle Scholar
  54. 54.
    Horwitz, K.B. (1994) How Do Breast Cancers Become Hormone Resistant? J. Steroid Biochem. Molec. Biol. 49, 295–302.PubMedCrossRefGoogle Scholar
  55. 55.
    Stephen, R., Corcoran, D., and Darbre, P.D. (1996) Retinoic Acid Inhibits Growth of Breast Cancer Cells in the Short-Term but Not the Long-Term, Biochem. Soc. Trans. 24, 365S.Google Scholar

Copyright information

© AOCS Press 1998

Authors and Affiliations

  • Kalanithi Nesaretnam
    • 1
  • Ruth Stephen
    • 1
  • Ray Dils
    • 1
  • Philippa Darbre
    • 1
  1. 1.Division of Cell and Molecular Biology, School of Animal and Microbial SciencesThe University of ReadingReadingEngland
  2. 2.Palm Oil Research Institute of MalaysiaKuala LumpurMalaysia

Personalised recommendations